跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
MEROPENEM LABATEC IV POWDER FOR INJECTION OR INFUSION 500MG/VIAL
Approved
THERAPEUTIC
MEROPENEM LABATEC IV POWDER FOR INJECTION OR INFUSION 500MG/VIAL
ACS DOBFAR S.P.A - ITALYACS DOBFAR S.P.A. (INTERMEDIATE) (ITALY)
🇸🇬 Health Sciences Authority
Approval Date
Nov 10, 2014
Approval ID
1c62cff4e2a893e7
Company
ACS DOBFAR S.P.A - ITALYACS DOBFAR S.P.A. (INTERMEDIATE) (ITALY)
Type
Therapeutic
Approval Details
Approval Id
1c62cff4e2a893e7
Drug Name
MEROPENEM LABATEC IV POWDER FOR INJECTION OR INFUSION 500MG/VIAL
Product Name
MEROPENEM LABATEC IV POWDER FOR INJECTION OR INFUSION 500MG/VIAL
Approval Number
SIN14660P
Approval Date
2014-11-10
Registrant
ALLIANCE PHARM PTE. LTD.
Licence Holder
ALLIANCE PHARM PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01DH02
Atc Item Name
meropenem
Pharma Manufacturer Name
ALLIANCE PHARM PTE. LTD.
Active Ingredients
Meropenem Trihydrate 570 mg eqv to Meropenem anhydrous
500mg
MEROPENEM TRIHYDRATE 570 MG EQV TO MEROPENEM ANHYDROUS
500 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 10, 2014
Approval ID
1c62cff4e2a893e7
Type
Therapeutic
Back to HSA Approvals
MEROPENEM LABATEC IV POWDER FOR INJECTION OR INFUSION 500MG/VIAL - HSA Drug Approval Details
